Vivani Medical VANI Cash and cash equivalents, end of period
Cash and cash equivalents, end of period at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's cash and cash equivalents, end of period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's cash and cash equivalents, end of period?
- Vivani Medical (VANI) reported cash and cash equivalents, end of period of $21.09M in Q1 2026.
- How has Vivani Medical's cash and cash equivalents, end of period changed year-over-year?
- Vivani Medical's cash and cash equivalents, end of period increased by 47.0% year-over-year, from $14.35M to $21.09M.
- What is the long-term trend for Vivani Medical's cash and cash equivalents, end of period?
- Over 5 years (2020 to 2025), Vivani Medical's cash and cash equivalents, end of period has grown at a 53.2% compound annual growth rate (CAGR), from $2.08M to $17.57M.